Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator

Cephalalgia

Volumn 36, Issue 6, 2016, Pages 552-560

  González Quintanilla, Vicente ^a   Toriello, María ^a   Palacio, Enrique ^a   González Gay, Miguel A ^a   Castillo, Jesús ^b   Montes, Silvia ^b   Martínez Nieto, Rosa ^b   Fernandez, Jenifer ^a   Rojo, Alvaro ^a   Gutiérrez, Silvia ^a   Pons, Enar ^a   Oterino, Agustín ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Health Service of Camargo Costa   (Spain)

Author keywords

cerebral vasoreactivity; chronic migraine; endothelial damage; flow mediated dilation; intima media thickness; Migraine; ultrasound study

Indexed keywords

C REACTIVE PROTEIN; VASOACTIVE AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD ANALYSIS; BREATH HOLDING INDEX; BREATHING; CASE CONTROL STUDY; CEREBRAL ENDOTHELIAL DYSFUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENDOTHELIAL DYSFUNCTION; EPISODIC MIGRAINE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW MEDIATED VASODILATION; HUMAN; HUMAN CELL; ICHD; MAJOR CLINICAL STUDY; MALE; SYSTEMIC ENDOTHELIAL DYSFUNCTION; TRANSFORMED MIGRAINE; ULTRASOUND; VASODILATATION; ADOLESCENT; ARTERIAL STIFFNESS; COMPLICATION; MIDDLE AGED; MIGRAINE; PATHOPHYSIOLOGY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; VASCULAR DISEASES; VASCULAR STIFFNESS; VASODILATION; YOUNG ADULT;

EID: 84968903235     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102415607857     Document Type: Article

References (36)

1. Olesen J, Leonardi M,. The burden of brain diseases in Europe. Eur J Neurol 2003; 10: 471-477.
2. Castillo J, Muñoz P, Guitera V, et al. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190-196.
3. Buse DC, Lipton RB,. Global perspectives on the burden of episodic and chronic migraine. Cephalalgia 2013; 33: 885-890.
4. Bigal ME, Lipton RB, Holland PR, et al. Obesity, migraine, and chronic migraine: Possible mechanisms of interaction. Neurology 2007; 68: 1851-1861.
5. Scher AI, Lipton RB, Stewart WF,. Habitual snoring as a risk factor for chronic daily headache. Neurology 2003; 60: 1366-1368.
6. Bigal ME, Lipton RB,. Excessive acute migraine medication use and migraine progression. Neurology 2008; 71: 1821-1828.
7. Rose KM, Wong TY, Carson AP, et al. Migraine and retinal microvascular abnormalities: The Atherosclerosis Risk in Communities Study. Neurology 2007; 68: 1694-1700.
8. Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: A population-based study. Neurology 2010; 74: 628-635.
9. Tietjen GE,. Migraine as a systemic vasculopathy. Cephalalgia 2009; 29: 989-996.
10. Lee ST, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008; 70: 1510-1517.
11. Tietjen GE, Herial NA, White L, et al. Migraine and biomarkers of endothelial activation in young women. Stroke 2009; 40: 2977-2982.
12. Headache Classification Committee, Olesen J, Bousser MG, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-746.
13. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
14. Corretti MC, Anderson TJ, Benjamin TJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
15. Silvestrini M, Cupini LM, Troisi E, et al. Estimation of cerebrovascular reactivity in migraine without aura. Stroke 1992; 26: 81-83.
16. Akgün H, Taşdemir S, Ulaş ÜH, et al. Reduced breath holding index in patients with chronic migraine. Acta Neurol Belg 2015; 115: 323-327.
17. Dora B, Balkan S,. Exaggerated interictal cerebrovascular reactivity but normal blood flow velocities in migraine without aura. Cephalalgia 2002; 22: 288-290.
18. Fiermonte G, Annulli A, Pierelli F,. Transcranial Doppler evaluation of cerebral hemodynamics in migraineurs during prophylactic treatment with flunarizine. Cephalalgia 1999; 19: 492-496.
19. Dora B, Balkan S, Tercan E,. Normalization of high interictal cerebrovascular reactivity in migraine without aura by treatment with flunarizine. Headache 2003; 45: 464-469.
20. Silvestrini M, Baruffaldi R, Bartolini M, et al. Basilar and middle cerebral artery reactivity in patients with migraine. Headache 2004; 44: 29-39.
21. Arjona A, de Torres LA, Serrano-Castro PJ, et al. A transcranial doppler study in interictal migraine and tension-type headache. J Clin Ultrasound 2007; 35: 372-375.
22. Vernieri F, Tibuzzi F, Pasqualetti P, et al. Increased cerebral vasomotor reactivity in migraine with aura: An autoregulation disorder? A transcranial Doppler and near-infrared spectroscopy study. Cephalalgia 2008; 28: 689-695.
23. Giusteto P, Liboni W, Mana O, et al. Joint metabolomics and instrumental analysis for the classification of migraine patients with 677-MTHFR mutations. Open Med Inform J 2010; 4: 23-30.
24. Perko D, Pretnar-Oblak J, Šabovič M, et al. Associations between cerebral and systemic endothelial function in migraine patients: A post-hoc study. BMC Neurol 2011; 11: 146-146.
25. Rajan R, Khurana D and Lal V. Interictal cerebral and systemic endothelial dysfunction in patients with migraine: A case-control study. J Neurol Neurosurg Psychiatry. Epub ahead of print 30 December 2014. DOI: 10.1136/jnnp-2014-309571.
26. Yetkin E, Ozisik H, Ozcan C, et al. Decreased endothelium-dependent vasodilation in patients with migraine: A new aspect to vascular pathophysiology of migraine. Coron Artery Dis 2006; 117: 29-33.
27. Vanmolkot FH, Van Bortel LM, de Hoon JN,. Altered arterial function in migraine of recent onset. Neurology 2007; 68: 1563-1570.
28. Silva FA, Rueda-Clausen CF, Silva SY, et al. Endothelial function in patients with migraine during the interictal period. Headache 2007; 47: 45-51.
29. de Hoon JN, Smits P, Troost J, et al. Forearm vascular response to nitric oxide and calcitonin gene-related peptide: Comparison between migraine patients and controls. Cephalalgia 2006; 26: 56-63.
30. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: The Atherosclerosis Risk in Communities Study. Neurology 2005; 64: 1573-1577.
31. Stam AH, Weller CM, Janssens AC, et al. Migraine is not associated with enhanced atherosclerosis. Cephalalgia 2013; 33: 228-235.
32. González-Juanatey C, Llorca J, Testa A, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003; 82: 407-413.
33. González-Juanatey C, Llorca J, González-Gay MA,. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Res Ther 2011; 13: R101-R101.
34. Telles RW, Lanna CC, Sousa AJ, et al. Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. Clin Rheumatol 2013; 32: 1293-1300.
35. Tam LS, Kitas GD, González-Gay MA,. Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) 2014; 53: 1108-1119.
36. Treib J, Stoll M, Hammann G, et al. Hemodynamics and breath holding test: Cerebrovascular diseases. Cerebrovasc Dis 1996; 6: 47-48.